Speaker:

Our first speaker is Dr. Kodsi.

Speaker:

He's an Australian-trained adult medicine physician who qualifications in palliative

Speaker:

medicine and pain medicine.

Speaker:

He has a special interest in musculoskeletal and neuropathic pain,

Speaker:

survivorship medicine, coordinating chronic and complex disease conditions,

Speaker:

cancer pain, comorbidity of pain with addiction.

Speaker:

Today, Dr. Kodsi will be speaking

Speaker:

about Chronic pain, post-surgical pain management. Thanks, Dr. Kodsi.

Speaker:

Let me start with a story, one that might be familiar to many of you in general practice.

Speaker:

Margaret's a 62-year-old retired teacher who's always been independent,

Speaker:

active and stoic when it comes to pain.

Speaker:

Six months ago, she underwent a routine mastectomy for early stage breast cancer.

Speaker:

The surgery was uneventful and her oncologist declared her cancer-free.

Speaker:

But Margaret hasn't felt free. She tells you, her GP, I still have this burning,

Speaker:

stabbing pain along the scar and into my armpit.

Speaker:

I can't sleep on that site. I can't wear a bra.

Speaker:

I can't even hug my grandchildren. It hurts.

Speaker:

You've checked the site. It's clean. No signs of infection.

Speaker:

Her surgeon says that the wound has healed. Her oncologist has moved on. But Margaret hasn't.

Speaker:

This is chronic post-surgical pain. It affects about half of patients undergoing

Speaker:

high risk procedures such as a mastectomy, thichotomy or an amputation.

Speaker:

It still occurs with hip and or other orthopedic surgeons but much in a much

Speaker:

less degree to about 15% and the most common place that it's diagnosed,

Speaker:

it's not in the theatre or the ward, it's in your office.

Speaker:

So today we'll be exploring chronic post-surgical pain and why it happens and

Speaker:

more importantly how we can all have a role in trying to prevent it together.

Speaker:

So hi everyone, I'm Anthony Kodsi, I'm a pain specialist and a palliative care

Speaker:

physician, otherwise known as an unofficial human complaint sponge.

Speaker:

I didn't always work in pain, I started general medicine, then I did palliative

Speaker:

care, but somehow along the way I kept being called into situations where the

Speaker:

patient was in pain and no one knew what to do next.

Speaker:

Eventually I realised that's my job now.

Speaker:

I often say that I meet patients when hope is waning thin and they've had the

Speaker:

surgery, they've done the rehab, they've tried the medications and the pain's

Speaker:

still no good. Or worse, it's even worse.

Speaker:

I lead the pain department in Concord Hospital and I work across tertiary hospitals

Speaker:

and I work alongside with the orthopedic surgeons here.

Speaker:

And I work in both interventional pain and supportive care.

Speaker:

My job is to step in when it starts to intrude on people's recovery or their life.

Speaker:

But ideally, we don't wait for that moment. Ideally, we can collaborate early,

Speaker:

before surgery, before opiate escalation, before the neural pathways lay down its tracks.

Speaker:

That's why I'm here today, because you as GPs are not only the first port of

Speaker:

call, you're the most consistent voice of patients here.

Speaker:

And that puts you in a very powerful position to change their trajectory.

Speaker:

Because the best chronic pain story is the one that never happens,

Speaker:

the one that doesn't need to see me.

Speaker:

So what do pain specialists do because I

Speaker:

believe that sometimes there is

Speaker:

a bit of misunderstanding or it's not

Speaker:

well known what we do I do a lot of medication management counseling and deprescribing

Speaker:

I help try to work out undifferentiated cases and some patients have had orthopedic

Speaker:

surgery and they had quite a good success structurally and good range of motion

Speaker:

but they still have persistent issues.

Speaker:

So I try to assist alongside with the orthopedic surgeon in that scenario.

Speaker:

I do diagnostic and therapeutic nerve blocks. I do some regenerative medicine

Speaker:

work. We have the facilities.

Speaker:

It's not always employed and there's a bit of difficult literature to go through

Speaker:

to know which ones work best for which type of joints.

Speaker:

Botox for refractory, spasticity and nerve pain and migraines particularly.

Speaker:

Where you could see ablation pulse treatments and neuromodulation.

Speaker:

And I work alongside you, the general practitioner and also the patient in a shared decision model.

Speaker:

Most patients, the chronic pain that they have is not an indicator of harm and

Speaker:

they should be able to mobilize and move.

Speaker:

And a lot of patients have had incomplete rehabilitation after their surgery

Speaker:

and they believe that pain had been a hindrance to that.

Speaker:

So they all quite benefit from physical therapies, exercise or prescribed activity.

Speaker:

And clinical psychologist because the burden of mental health problems with

Speaker:

chronic pain patients is very severe and significant.

Speaker:

So a bit of a history about chronic post-surgical pain.

Speaker:

So a seminal paper by Sherman et al.

Speaker:

40 years ago had a comprehensive mail questionnaire that was sent to 5,000 US

Speaker:

military veterans with limb amputations.

Speaker:

55% responded. This seminal survey showed a few findings.

Speaker:

Phantom limb pain was very prevalent.

Speaker:

About 78%, four-fifths of patients experienced phantom limb pain.

Speaker:

Most of them had a lot of disability from this phantom limb pain.

Speaker:

It didn't go away, no matter where it happened.

Speaker:

And a lot of them had coexisting stump pain. In fact, it was very rare to have

Speaker:

phantom limb pain without coexisting stump pain.

Speaker:

And what was surprising, since I've only been a doctor for about 15 to 20 years,

Speaker:

is that most of the treatments that they've all tried are very similar to what

Speaker:

we have today, 40 years later.

Speaker:

And only less than 1% reported lasting benefits from treatment.

Speaker:

So this kind of shows a really high prevalence and functional impact of chronic

Speaker:

post-surgical pain despite that the surgeons made sure that there's no other

Speaker:

underlying structural issues are gone and they treated anything that they could see.

Speaker:

Another seminal paper was a study 10 years later by Crombutyl and they had a

Speaker:

survey of 5,000 patients.

Speaker:

Sorry, this is too loud.

Speaker:

Of 10 chronic pain clinics in Northern Britain.

Speaker:

And they looked at the frequency of how many patients in the pain clinics were

Speaker:

due to surgery or trauma.

Speaker:

And they found about one-fifth of patients had surgery beforehand and is why

Speaker:

they're in the pain clinic.

Speaker:

So this is a very high prevalence of post-surgical pain issues.

Speaker:

And most of them didn't have any other underlying pathology.

Speaker:

The surgeons cleared them and they still had persistent pain.

Speaker:

This also is a study that showed that the demographics between the surgery-related

Speaker:

pain and those who had trauma-related pain were quite different and stark.

Speaker:

So, 10 years later, before the ICD-11 and ICD-10 and other diagnostic manuals,

Speaker:

they're starting to coin the word chronic post-surgical pain.

Speaker:

And most of them try to reclassify them to other types of what surgeries they

Speaker:

had because they had very different risk profiles.

Speaker:

And arthroplasty also was seen as well.

Speaker:

And most of it defines pain as that persists three months after the recurrence

Speaker:

or persistence of the pain. So it has to stay for longer than three months to

Speaker:

be considered chronic post-surgical pain.

Speaker:

And it began or increased after surgery, usually in that very post-operative

Speaker:

window or in a few months after the surgery.

Speaker:

It's in the area of the surgery and it needs to be going on for three months.

Speaker:

And they've excluded the most common causes, which is usually infection,

Speaker:

the pre-existing condition, and the NCR and ER of alternative cause.

Speaker:

The reason why this is different from acute pain is that acute pain is a physiological

Speaker:

response to tissue injury.

Speaker:

It is protective and it's usually time-limited.

Speaker:

Chronic pain, on the other hand, involves neuroplastic changes that sustain

Speaker:

pain long after tissue healing, and I'll be talking about that in a minute.

Speaker:

The pain persists without ongoing noise-disceptive input, suggesting that there

Speaker:

is central mechanisms of wind-up and loss of descending inhibitory control.

Speaker:

So what happens? So interestingly, in the preoperative phase,

Speaker:

people are set up to have failure and to have chronic pain.

Speaker:

The odds ratio for certain demographic behaviours that are biologically not

Speaker:

under anyone's control is being female, being younger sex, and having coexisting

Speaker:

or chronic pain issues to start off with.

Speaker:

Also psychological distress, being prone to catastrophic beliefs,

Speaker:

Catastrophic beliefs have been probably the number one thing that's been now

Speaker:

starting in the last 10 years Of trying to reduce that preoperatively to see

Speaker:

if that improves and stops bad post-surgical outcomes,

Speaker:

Unfortunately, most education and other interventions have not shown to really

Speaker:

benefit or is either prohibitively too costly.

Speaker:

The other thing that I'll talk about in a second is preoperative opioid use.

Speaker:

And then after the postoperative period in our pain rounds, we look at these

Speaker:

type of things, whether they had catastrophic beliefs there and we give them education.

Speaker:

We look at also the other things. In the preoperative planning stage,

Speaker:

I often talk to the anaesthetists about what their usual protocol or regime is,

Speaker:

their regional blockade to try to reduce central sensitization and what kind

Speaker:

of adjuvant analgesics can decrease wind-up pain.

Speaker:

The surgical technique is also important.

Speaker:

Preoperative opioids have been shown to have a very strong negative impact on a patient's recovery.

Speaker:

It affects infection rates, readmission, prolonged stay,

Speaker:

it causes higher costs and complications and longer hospital stays and they

Speaker:

have worse pain and functional outcomes and it's not very clear that the opioid

Speaker:

use just signifies that they have severe pain or a problem to start off with.

Speaker:

It's really just the opioids.

Speaker:

And tapering and multimodal strategies have been always suggested to try to reduce the risk.

Speaker:

In fact, if you reduce the opioids by about 50% within two to three months before

Speaker:

their operation, their risk is substantially decreased and they usually behave

Speaker:

like the baseline population.

Speaker:

The incidence per procedure is quite significant.

Speaker:

And for our purposes today, amputation and hip arthroprasty and knee arthroprasty

Speaker:

still have significant risks of chronic post-surgical pain.

Speaker:

The surgical risk factors is not surprising at all.

Speaker:

High tissue trauma surgeries have quite significant rates of chronic post-surgical pain.

Speaker:

Nerve injury during surgery is another factor and adequate acute pain control.

Speaker:

And surgical techniques, a study by Melko et al looked at prophylactic in the

Speaker:

inner nerve excision during hernia repair.

Speaker:

This is a famous study, and it found actually, interestingly,

Speaker:

that if you excise the ingling nerve, there was less pain than just preserving

Speaker:

the ingling nerve and it being under pressure by the mesh.

Speaker:

So surgical techniques are always in every kind of field of surgery.

Speaker:

There's always ongoing discussions about how best to reduce the risk of nerve

Speaker:

injury and reduce chronic pain.

Speaker:

So the reason for chronic pain involves both peripheral things that happen in

Speaker:

the tissues and central sensitization.

Speaker:

Peripheral injury causes a release of inflammatory mediators,

Speaker:

particularly calcitonin receptor gene peptide, which lowers noisiceptive thresholds.

Speaker:

It causes sensitization of the existing noisiceptive fibers.

Speaker:

It causes more noisiceptive fibers. It causes collateral sprouting.

Speaker:

It couples with the sympathetic overflow, which also lowers,

Speaker:

again, the noisiceptive thresholds.

Speaker:

And where nerve is cut, there is a nervi neborum.

Speaker:

And central mechanisms also exist. Sensitization and other things that happen

Speaker:

in the dorsal horn of the spine increases its more input and trafficking of

Speaker:

noisiceptive signals and decreases dysinibutory control.

Speaker:

So I'm going to talk about a controversial subject, but I'll talk about what we seem to know so far.

Speaker:

We used to think preventative analgesia might be helpful, but there has been

Speaker:

a lot of fortunate research in that department and less is known about where

Speaker:

the place of preventative analgesia is.

Speaker:

What is less controversial is the use of pre-emptive analgesia.

Speaker:

So pre-emptive analgesia is treatment given prior to the incision.

Speaker:

Pre-emptive analgesia is giving

Speaker:

analgesia before and during and after the operation and the closure.

Speaker:

The idea is this, that during surgery there's a lot of noise deceptive input

Speaker:

and then there's less as the patient recovers from that first day and then they

Speaker:

get another phase of increased noise deceptive input, more swelling,

Speaker:

more inflammation, etc.

Speaker:

And the hypersensitivity that occurs if you measure it also follows that noise deceptive input.

Speaker:

If we just gave analgesia after the surgery, we might dampen that neurodeceptive

Speaker:

input for a little bit, but that hypersensitivity doesn't really shift.

Speaker:

If we gave pre-surgical analgesia, the idea is that they might not get much

Speaker:

hypersensitivity from any inflammation, etc., that occurs in the operation,

Speaker:

but they still will get hypersensitivity and that doesn't seem to improve outcomes

Speaker:

for chronic post-surgical pain.

Speaker:

The idea is that with pre-emptive analgesia,

Speaker:

analgesia given throughout the trajectory for both in the operation and after

Speaker:

closure that we can dampen or reduce or mitigate hypersensitivity.

Speaker:

How do we measure hypersensitivity? One thing that we often do is look for alodynia

Speaker:

by using a von Frey filament near the incision. So they're always quite tender.

Speaker:

But using a filament that shouldn't cause pain or is not that noxious,

Speaker:

if they feel allodyneed towards that, then they're likely very sensitized.

Speaker:

So a study, a nice study was done

Speaker:

by Levander-Home in 2005 looking at interoperative epidural analgesia.

Speaker:

This was 85 patients with colonic cancer resected. They had two interventions.

Speaker:

They all had epidural 30 minutes before incision and they had treatment between

Speaker:

the incision and closure and then second are after skin closure.

Speaker:

So all patients had a thoracic epidural catheter and both had IV and epidural infusions.

Speaker:

Some of them though would have the study medication and the others would have saline.

Speaker:

The consistent story is this.

Speaker:

That if they had epidural buprenorphine, sorry,

Speaker:

bubivacaine, and they had good analgesia postoperatively, their outcomes were very different.

Speaker:

They had better postoperative pain, they were able to mobilize and cough,

Speaker:

and this is surprising with epidurals because that caused hypertension and they

Speaker:

might have less ability to mobilize because of just having the catheter.

Speaker:

And they had decreased normally pain consistently.

Speaker:

They were able to do other functional outcomes postoperatively.

Speaker:

And the interesting thing is that they all had decreased hypersensitization.

Speaker:

So when they were tested, they had much less sensitization in the epidural groups.

Speaker:

And this had a translation effect months after the surgery.

Speaker:

Those that received preemptive analgesia had decreased rates of chronic pain six or 12 months later.

Speaker:

So in the orthopedic space, they don't often use epidural catheters.

Speaker:

They often do regional analgesia and that has been shown to be just as good

Speaker:

and might be safer than epidural catheters in reducing sensitization.

Speaker:

The other techniques that we use, using gabapentinoids,

Speaker:

etc., they had its place but it increases sedation risks and other problems

Speaker:

in the postoperative periods and their benefit compared to their risks,

Speaker:

haven't been shown to be something that we should be routinely using.

Speaker:

In the post-operative phase, me as a pain specialist often tries to reduce their

Speaker:

opioid use and look at their functional pain assessment outcomes rather than just the pain scores.

Speaker:

And I also look for whether they have neuropathic pain because when they have neuropathic pain,

Speaker:

they are more likely to benefit from a neuropathic agent to try to reduce their

Speaker:

pain and reduce their opioid consumption as well.

Speaker:

So I look for aledonia, I use the static and dynamic superficial techniques,

Speaker:

I use a pin or I use a toothpick or a clip,

Speaker:

I use a dynamic brush to see if there's a brush aledonia and I try to diagnose

Speaker:

whether they have neuropathic pain as a reason for their high opioid use postoperatively.

Speaker:

So opioids have a lot of risks that we'll discuss in the next slide.

Speaker:

I often try to use non-steroidals as well with the surgeon's permission,

Speaker:

particularly because it can affect healing.

Speaker:

That's always a contentious issue of discussion.

Speaker:

But a lot of surgeries have been shown that preoperatively even,

Speaker:

that high doses of lexamethasone or COX-2 inhibitor like celicoxib can reduce

Speaker:

their post-operative pain and outcomes.

Speaker:

So this is worth discussing with your surgeon.

Speaker:

Gabapentanoids, in some protocols,

Speaker:

gabapentanoids have been shown to be helpful preoperatively to be used,

Speaker:

such as with shoulder surgery, but they also have its own risk profile and in

Speaker:

the elderly particularly,

Speaker:

they're much less likely to tolerate it.

Speaker:

Ketamine has its place but also not always well tolerated and IV lidocaine for short term as well.

Speaker:

So, we have in the post-operative phase, we have a lot of options of opioids to use.

Speaker:

Because today we're talking about the elderly, I have a few things to say.

Speaker:

So fentanyl PCAs we often use because it's very short and it's more forgiving

Speaker:

in renal failure, which is very common in the elderly.

Speaker:

But it's not a great analgesic all the time because it has tachyphylaxis.

Speaker:

So I don't know if anyone has tritrated a fentanyl patch before and gone to

Speaker:

really high figures and not getting much pain relief.

Speaker:

That's a property of fentanyl that doesn't seem to happen with other opioids.

Speaker:

Another issue with fentanyl is because it has less euphoric effects.

Speaker:

Some patients don't seem to get much benefit until we switch over to morphine or oxycodone.

Speaker:

Morphine is very well tolerated still, but it has a more high incidence of nausea

Speaker:

and histamine release compared to oxycodone.

Speaker:

So oxycodone is preferred in many places.

Speaker:

That said, very quickly we try to transition them from pure opioid agonists

Speaker:

to pentadol or buprenorphine.

Speaker:

And you might have noticed in the last five years that you're getting a lot

Speaker:

of these post-op patients now on polexia and buprenorphine.

Speaker:

But I'll say another thing. Tepentadol in the elderly has a higher risk of delirium.

Speaker:

It also does seem to have a lowest seizure threshold, a bit more than other

Speaker:

opioids and maybe a bit less than tramadol.

Speaker:

It still has a bit of a small risk of increased constipation compared to the other things.

Speaker:

And Tepentadol in Australia at least is not very titratable.

Speaker:

In the United States, Tepentadol comes in as an oral syrup. It comes in 25 milligrams.

Speaker:

We don't have these things, and that limits its use in the elderly.

Speaker:

So in a few hospitals that I work with, terpentadol is not usually used for patients above 70 or 75.

Speaker:

Buprenorphine, though, there is increased and increased data and more studies,

Speaker:

particularly where I come from in Royal Prince Alfred, of using low doses of buprenorphine.

Speaker:

It seems to be much more tolerated. Now the reason to talk about both dipentadol

Speaker:

and buprenorphine and how this fits in opioid stewardship these days is these

Speaker:

are both what's called atypical opioids.

Speaker:

They are not pure opioid agonists and most of their mechanism for pain relief

Speaker:

does not seem to be just their new opioid receptor agonist activity.

Speaker:

It's more due to other mechanisms. That also decreases sensitization.

Speaker:

And so therefore, it's not yet proven

Speaker:

but there seems to be that if

Speaker:

we shift to these other less drugs not

Speaker:

only are patients less likely to misuse or

Speaker:

abuse them in the post-operative period or continue to use them months and months

Speaker:

later but it might have an impact in decreasing central sensitization in the

Speaker:

post-operative period and thus decreasing the risk of chronic post-surgical pain.

Speaker:

Another thing in the post-operative setting is

Speaker:

that sometimes patients have increasing opioid use even in the community after

Speaker:

they've been discharged and it's not explainable by believing that there might

Speaker:

be a missed pathology or that the surgeons need to look again as to what is occurring.

Speaker:

And that is diagnosed by a

Speaker:

higher index of suspicion and the pain usually is very diffuse and poorly localized

Speaker:

even beyond the surgical site and there's aladynia as I described on how to

Speaker:

test and there's a lack of response when you escalate the opioid.

Speaker:

So it could be neuropathic pain, that's the other differential and this usually

Speaker:

occurs when the pure opioid agonists are used as well.

Speaker:

So what do we do? I often try to rotate the opioid to try to mitigate the risks

Speaker:

of the opioid-induced hyperalgesia.

Speaker:

In the inpatient setting, I might use other treatments and in your setting,

Speaker:

anti-inflammatories and gabapentinoids might be beneficial.

Speaker:

So multimodal strategies are not only helpful in the intraoperative phase,

Speaker:

it is still useful in the postoperative and in the community setting.

Speaker:

And opioid sparing strategies like early rehabilitation is also important.

Speaker:

So takeaways, post-surgical pain is persistent and recurrent pain lasting more

Speaker:

than three months after surgery, after excluding other causes.

Speaker:

The risk factors for chronic post-surgical pain is not just the surgery,

Speaker:

it's also biological and demographic factors.

Speaker:

And in particular, there are multiple factors, particularly still under your

Speaker:

control, which is a preoperative opioid use and their psychological distress.

Speaker:

The surgical impact has a key relationship with their chronic post-surgical risk history.

Speaker:

There are preventative ways that both you and the anaesthetist,

Speaker:

and pain specialist can employ in putting multimodal analgesic strategies even

Speaker:

before incision and opioid management is important to mitigate the risks And

Speaker:

if we look at the opioid and be stewards for them,

Speaker:

we can also reduce possibly the chronic post-surgical pain history.

Speaker:

Okay. So, thank you.